LISRAYA™ (brepocitinib) 30 mg tablets
Lisraya is indicated for the treatment of adults with dermatomyositis.
To read important safety information please click here.
Lisraya is indicated for the treatment of adults with dermatomyositis.
To read important safety information please click here.